ANDA 205531, held by Rising Pharmaceuticals. Metronidazole.
As of Nov 21, 2026, ANDA 205531 (Metronidazole In Plastic Container), held by Rising Pharmaceuticals, was first approved by FDA on May 9, 2017, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 9, 2017 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metronidazole In Plastic Container500MG/100ML · injectable;injection | Metronidazole | Discontinued |
| Oct 19, 2026 | Supplement 2Labeling · Standard review | Approved | None posted |
| Oct 19, 2026 | Supplement 3Labeling · Standard review | Approved | None posted |
| Nov 5, 2019 | Supplement 1Labeling · Standard review | Approved | None posted |
| May 9, 2017 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters